Abstract:BACKGROUND:Human myelogenous leukemia characterized by either the non random t(8; 21)(q22; q22) or t(16; 21)(q24; q22) chromosome translocations differ for both their biological and clinical features. Some of these features could be consequent to differential epigenetic transcriptional deregulation at AML1 targets imposed by AML1-MTG8 and AML1-MTG16, the fusion proteins deriving from the two translocations. Preliminary findings showing that these fusion proteins lead to transcriptional downregulation of AML1 targets, marked by repressive chromatin changes, would support this hypothesis. Here we show that combining conventional global gene expression arrays with the power of bioinformatic genomic survey of AML1-consensus sequences is an effective strategy to identify AML1 targets whose transcription is epigenetically downregulated by the leukemia-associated AML1-MTG16 protein. RESULTS:We interrogated mouse gene expression microarrays with probes generated either from 32D cells infected with a retroviral vector carrying AML1-MTG16 and unable of granulocyte differentiation and proliferation in response to the granulocyte colony stimulating factor (G-CSF), or from 32D cells infected with the cognate empty vector. From the analysis of differential gene expression alone (using as criteria a p value < 0.01 and an absolute fold change > 3), we were unable to conclude which of the 37 genes downregulated by AML1-MTG16 were, or not, direct AML1 targets. However, when we applied a bioinformatic approach to search for AML1-consensus sequences in the 10 Kb around the gene transcription start sites, we closed on 17 potential direct AML1 targets. By focusing on the most significantly downregulated genes, we found that both the AML1-consensus and the transcription start site chromatin regions were significantly marked by aberrant repressive histone tail changes. Further, the promoter of one of these genes, containing a CpG island, was aberrantly methylated. CONCLUSION:This study shows that a leukemia-associated fusion protein can impose a distinct epigenetic repressive signature at specific sites in the genome. These findings strengthen the conclusion that leukemia-specific oncoproteins can induce non-random epigenetic changes.

HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

A Distinct Epigenetic Signature at Targets of a Leukemia Protein

A Novel Role for Malate Dehydrogenase 1 in Acute Myeloid Leukemia Progression

The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1b-mediated AML progression

Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid Leukemia

Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia

HIF-1 α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation

The Non-Cell-autonomous Function of ID1 Promotes AML Progression Via ANGPTL7 from the Microenvironment.

The Association Between Expression of Hypoxia Inducible Factor-1Α and Multi-Drug Resistance of Acute Myeloid Leukemia

Silencing HIF-1α Reduces the Adhesion and Secretion Functions of Acute Leukemia Hbmscs

HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia

Physical and Functional Interactions of Acute Myeloid Leukemia-1 with Hypoxia Inducible Factor-1α Protein.

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Hypoxia-inducible Factor-1Α-induced Differentiation of Myeloid Leukemic Cells is Its Transcriptional Activity Independent

HIF-2α inhibition disrupts leukemia stem cell metabolism and impairs vascular microenvironment to enhance chronic myeloid leukemia treatment

Hypoxic Exposure Activates the B Cell-Specific Moloney Murine Leukaemia Virus Integration Site 1/pi3k/akt Axis and Promotes EMT in Leukaemia Stem Cells

Hypoxia-HIF-1α-C/EBPα/Runx1 signaling in leukemic cell differentiation

HIF1α is Required for Survival Maintenance of Chronic Myeloid Leukemia Stem Cells.

YTHDF2 is a Potential Target of AML1/ETO-HIF1α Loop-Mediated Cell Proliferation in T(8;21) AML

Epigenetic control over cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia

RHOF Activation of AKT/β-Catenin Signaling Pathway Drives Acute Myeloid Leukemia Progression and Chemotherapy Resistance